{
    "body": "Do ephrins play a role in brain cancer?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18794797", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16254188", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23686814", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18366728", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15126357", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15473927", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19728339", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16951161", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20571968", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19270726", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22723427", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22688511", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14726470", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10984508", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18089715", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22374425", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17332925"
    ], 
    "ideal_answer": [
        "Eph receptors and ephrin ligands are involved in the development of the central nervous system. Their expression is often reported to be up-regulated in brain tumours and they may be considered molecular markers for the diagnosis of invasive and metastatic tumours. However, there are also reports describing the down-regulation of the Eph/ephrin family in brain cancer."
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D036342", 
        "http://www.disease-ontology.org/api/metadata/DOID:162", 
        "http://www.disease-ontology.org/api/metadata/DOID:1319", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001932", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0046875"
    ], 
    "type": "summary", 
    "id": "53442472aeec6fbd07000008", 
    "snippets": [
        {
            "offsetInBeginSection": 1504, 
            "offsetInEndSection": 1745, 
            "text": "migrating glioblastoma cells overexpress EphB2 in vitro and in vivo; glioma migration and invasion are promoted by activation of EphB2 or inhibited by blocking EphB2. Dysregulation of EphB2 expression or function may underlie glioma invasion", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15126357", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 13, 
            "offsetInEndSection": 93, 
            "text": "gene expression of Eph receptors and ephrins in benign human tissues and cancers", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14726470", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1128, 
            "offsetInEndSection": 1175, 
            "text": "EphA1/EphA8 was down-regulated in glioblastomas", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14726470", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 16, 
            "offsetInEndSection": 75, 
            "text": "EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10984508", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1605, 
            "offsetInEndSection": 1724, 
            "text": "high-level expressions of favorable NB genes, such as EPHB6, can in fact suppress malignant phenotype of unfavorable NB", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10984508", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1, 
            "offsetInEndSection": 117, 
            "text": "phrin-As, Eph receptors and integrin \u03b13 interact and colocalise at membrane protrusions of U251MG glioblastoma cells", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23686814", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1131, 
            "offsetInEndSection": 1256, 
            "text": "crosstalk between Eph and integrin signalling pathways at the membrane protrusions and in the migration of brain cancer cells", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23686814", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1, 
            "offsetInEndSection": 91, 
            "text": "phB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22723427", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1296, 
            "offsetInEndSection": 1474, 
            "text": "deregulation of Eph/ephrin expression in medulloblastoma enhances the invasive phenotype, suggesting a potential role in local tumor cell invasion and the formation of metastases", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22723427", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1, 
            "offsetInEndSection": 53, 
            "text": "phrinA1 is released in three forms from cancer cells", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22688511", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1, 
            "offsetInEndSection": 152, 
            "text": "phrinA1 is a glycosylphosphatidylinositol (GPI)-linked ligand for the EphA2 receptor, which is overexpressed in glioblastoma (GBM), among other cancers", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22688511", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 14, 
            "offsetInEndSection": 133, 
            "text": "EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22374425", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1418, 
            "offsetInEndSection": 1621, 
            "text": "EphrinB2 and EphB4 expressions increase according to the histopathological grade and KPS score of glioma, and their expression levels are related to the progression-free survival of glioblastoma patients", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22374425", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1, 
            "offsetInEndSection": 138, 
            "text": "p-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571968", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 10, 
            "offsetInEndSection": 81, 
            "text": "gliomas display over-expression of the receptor tyrosine kinase EphA2. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571968", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 4, 
            "offsetInEndSection": 83, 
            "text": "phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19728339", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1624, 
            "offsetInEndSection": 1824, 
            "text": "high expression of ephrin-B2 is a strong predictor of short-term survival and that ephrin-B2 plays a critical role in glioma invasion rendering this signaling pathway as a potential therapeutic target", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19728339", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1, 
            "offsetInEndSection": 45, 
            "text": "phrinA5 acts as a tumor suppressor in glioma", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19270726", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 253, 
            "offsetInEndSection": 354, 
            "text": "expression of ephrinA5 was dramatically downregulated in primary gliomas compared with normal tissues", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19270726", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 4, 
            "offsetInEndSection": 54, 
            "text": "EphA2 receptor and ephrinA1 ligand in solid tumors", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19074825", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 228, 
            "offsetInEndSection": 414, 
            "text": "investigating the ephrinA1/EphA2 system in the pathobiology of glioblastoma multiforme (GBM), we uncovered that ephrinA1 is released from GBM and breast adenocarcinoma cells as a soluble", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18794797", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 450, 
            "offsetInEndSection": 569, 
            "text": "ccumulating evidence indicates that Eph and ephrins are frequently overexpressed in different tumor types including GBM", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18366728", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 34, 
            "offsetInEndSection": 201, 
            "text": "EphA2 receptor tyrosine kinase is overexpressed in glioblastoma multiforme (GBM) and represents a novel, attractive therapeutic target for the treatment of brain tumor", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18089715", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1, 
            "offsetInEndSection": 43, 
            "text": "phrin-A1 is a negative regulator in glioma", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332925", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 977, 
            "offsetInEndSection": 1059, 
            "text": " ephrin-A1 serves as a critical negative regulator in the tumorigenesis of gliomas", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332925", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 275, 
            "offsetInEndSection": 338, 
            "text": "overexpression of EphB2 in glioma cells increases cell invasion", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16951161", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1, 
            "offsetInEndSection": 71, 
            "text": "phA2 as a novel molecular marker and target in glioblastoma multiforme", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16254188", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1127, 
            "offsetInEndSection": 1240, 
            "text": "EphA2 is both specifically overexpressed in GBM and expressed differentially with respect to its ligand, ephrinA1", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16254188", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 247, 
            "offsetInEndSection": 300, 
            "text": "EphB4 and EphrinB2 protein expression in astrocytomas", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15473927", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1144, 
            "offsetInEndSection": 1242, 
            "text": "Expressions of EphB4 and EphrinB2 proteins may be related to differentiation degree of tumor cells", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15473927", 
            "endSection": "abstract"
        }
    ]
}